List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 11 studies with search of: "Mallinckrodt" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets
Condition: Healthy
Interventions: Drug: Oxycodone hydrochloride tablet 30 mg;   Drug: Roxicodone™ tablet 30 mg
2 Completed Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets
Condition: Healthy
Interventions: Drug: Oxycodone hydrochloride tablet 15 mg;   Drug: Roxicodone™ tablet 15 mg
3 Completed Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets
Condition: Healthy
Interventions: Drug: Roxicodone™ tablet 30 mg;   Drug: Oxycodone hydrochloride tablet 30 mg
4 Completed Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets
Condition: Healthy
Interventions: Drug: Hydromorphone Hydrochloride tablet 8 mg;   Drug: Dilaudid® tablet 8 mg
5 Recruiting Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection
Conditions: Nephrogenic Systemic Fibrosis;   Renal Insufficiency
Intervention:
6 Completed Fed Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets
Condition: Healthy
Interventions: Drug: Controlled-Release Oxycodone Hydrochloride 40 mg;   Drug: OxyContin® 40 mg tablet
7 Recruiting Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography
Condition: Renal Impairment
Interventions: Drug: Ioversol 320 mgI/mL;   Drug: Iodixanol 320 mgI/mL
8 Completed Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension
Condition: Healthy
Interventions: Drug: Chlorpheniramine polistirex equivalent to 8 mg of chlorpheniramine maleate and hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate capsule;   Drug: 5 mL chlorpheniramine (8 mg/5 mL)/hydrocodone (10 mg/5 mL) extended release oral suspension
9 Completed Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets
Condition: Healthy
Interventions: Drug: Controlled-Release Oxycodone Hydrochloride 40 mg tablet;   Drug: OxyContin® 40 mg tablet
10 Completed Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension
Condition: Healthy
Interventions: Drug: Chlorpheniramine polistirex equivalent to 8 mg of chlorpheniramine maleate and hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate capsule;   Drug: 5 mL chlorpheniramine (8 mg/5 mL)/hydrocodone (10 mg/5 mL) extended release oral suspension
11 Completed The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity
Condition: Breast Cancer
Intervention: Drug: Doxorubicin

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services